title: Heparin-induced thrombocytopenia in 2017 and beyond.
authors.affiliation: Tamam Bakchoul, MD, Center for Clinical Transfusion Medicine, University Hospital of Tübingen, Otfried-Müller-Straße 4/1, 72076 Tübingen, Germany, Tel.: +49 7071 29 81601, Fax: +49 7071 29 5240, E-mail: tamam.bakchoul@med.uni-tuebingen.de.
authors.forename: Tamam
authors.initials: T
authors.lastname: Bakchoul
authors.forename: Andreas
authors.initials: A
authors.lastname: Greinacher
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
mesh_terms: D001792:Blood Platelets / Q000166:cytology / Q000187:drug effects; D006348:Cardiac Surgical Procedures; D002309:Cardiology / Q000379:methods* / Q000639:trends; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D009000:Monocytes / Q000166:cytology / Q000187:drug effects; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000503:physiopathology*
chemical_list: D006493:Heparin